Clinical Decision Support Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: October 27, 2022 Report Code: GDME1465EPD-ST

Select Item

Clinical Decision Support Systems Pipeline Products Market Overview

The Clinical Decision Support Systems pipeline market research report provides comprehensive information about the Clinical Decision Support Systems pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Clinical Decision Support Systems Pipeline Products Market Segmentation, by Territories

Some of the key territories with products in the pipeline are the US, Europe, China, Canada, Mexico, the UK, Australia, Israel, India, and South Korea. As of October 2022, the US has the highest number of products in the pipeline out of them all.

Clinical Decision Support Systems Pipeline Products Market Analysis, by Territories, 2022 (%)

Clinical Decision Support Systems Pipeline Products Market Analysis, by Territories

For more territory insights into the clinical decision support systems pipeline products market, download a free report sample

Clinical Decision Support Systems Pipeline Products Market Segmentation by Key Regulatory Paths

The key regulatory paths followed by the clinical decision support systems pipeline products market are CE, 510(k), de novo, NMPA, TGA, UKCA, CLIA, ICAC, MDL, NIFDS, and PMA. Most of the products follow the CE pathway to enter the market.

Clinical Decision Support Systems Pipeline Products Market Analysis, by Regulatory Paths, 2022 (%)

Clinical Decision Support Systems Pipeline Products Market Analysis, by Regulatory Paths

For more clinical decision support systems pipeline products market regulatory path insights, download a free report sample

Competitive Landscape

Some of the leading companies in the clinical decision support systems pipeline products market are Aalborg University, Abiomed Inc, Aclarion Inc, Adaptive Technology Consulting LLC, Admera Health LLC, Advinow Inc, AHEPA University Hospital, AI Medical Technology AB, ai4gi Solutions Inc, and AI4medicine.

Aalborg University: It is a Danish public university that offers educational and research programs like bachelor’s programs, master’s programs, doctoral programs, student guidance programs, degree courses, educational and research services and programs. It offers its services through its facilities, campuses, and departments. AAU is headquartered in Aalborg, Denmark.

Abiomed Inc: It is a medical device company that develops, manufactures, and markets circulatory support devices. Abiomed also offers online clinical support through Impella Connect, on-call assistance, and on-site assistance for health workers in hospitals. The company sells its products through direct sales and distributors in South America, Europe, Asia, and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US. 

Aclarion Inc: It is a provider of healthcare technology solutions. The company is headquartered in San Mateo, California, US.

Clinical Decision Support Systems Pipeline Products Market Report Overview

Key Territories The US, Europe, China, Canada, Mexico, the UK, Australia, Israel, India, and South Korea
Key Regulatory Paths CE, 510(k), de novo, NMPA, TGA, UKCA, CLIA, ICAC, MDL, NIFDS, and PMA
Leading Companies Aalborg University, Abiomed Inc, Aclarion Inc, Adaptive Technology Consulting LLC, Admera Health LLC, Advinow Inc, AHEPA University Hospital, AI Medical Technology AB, ai4gi Solutions Inc, and AI4medicine

Segments Covered in the Report

Clinical Decision Support Systems Pipeline Products Market Territories Outlook

  • The US
  • Europe
  • China
  • Canada
  • Mexico
  • The UK
  • Australia
  • Israel
  • India
  • South Korea

Clinical Decision Support Systems Pipeline Products Market Regulatory Paths Outlook

  • CE
  • 510(k)
  • de novo
  • NMPA
  • TGA
  • UKCA
  • CLIA
  • ICAC
  • MDL
  • NIFDS
  • PMA

Scope

This report provides:

  • Extensive coverage of the Clinical Decision Support Systems under development.

  • Details of major pipeline products which include product description, licensing, collaboration details, and other developmental activities.

  • Reviews of the major players involved in the development of Clinical Decision Support Systems and lists all their pipeline projects.

  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.

  • Identify and understand important and diverse types of Clinical Decision Support Systems under development.

  • Develop market-entry and market expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Aalborg University
Abiomed Inc
Aclarion Inc
Adaptive Technology Consulting LLC
Admera Health LLC
Advinow Inc
AHEPA University Hospital
AI Medical Technology AB
ai4gi Solutions Inc
AI4medicine
Ai-Assisted Hematologic Analytic and Decision Support
Aidoc Ltd
Aifred Health Inc
Aignostics GmbH
AirStrip Technologies Inc
Alan Turing Institute Almere
AlertWatch Inc
AlgorithmRx, LLC
All India Institute of Medical Sciences
Allegheny-Singer Research Institute
American College of Rheumatology
Ampel BioSolutions LLC
Analytic Diabetic Systems, LLC
Anumana Inc
Apollo Medical Imaging Technology Pty Ltd
Arne BV
Atomo Inc
Auckland University of Technology
Automated Reliable Tissue Diagnostics AG
Automedics Medical Systems Inc (Inactive)
Autonomous Healthcare Inc
Bausch & Lomb Inc
Bayer AG
Beijing Infervision Technology Co Ltd
Ben-Gurion University of the Negev
Berg LLC
bioMerieux Inc
BioSensics LLC
Blenderhouse
Blue Eye Soft Corp
Brain Electrophysiology Laboratory LLC
Brainomix Ltd
BrightOutcome Inc.
Cardiogram Inc
CareDx Inc
Carevive Systems Inc
Carnegie Mellon University
Case Western Reserve University
Cellnovo Ltd (Inactive)
Children's Hospital of Philadelphia
Children's Research Institute
Cohere Health Technologies LLC
Columbia University
Combinostics Oy
Computer Technology Associates Inc
ContextVision AB
Corin Group Ltd
CorticoMetrics LLC
Crosscope Inc
Cumulus Neuroscience Ltd
Curemetrix Inc
Dascena Inc
Daxor Corp
Deontics Ltd
Directed Systems Ltd
Doctrin AB
Dokkyo Medical University
DSX Therapeutics LLC
Eko Devices Inc
Embryonics Ltd
Encompass Health Corp
Ensofy Inc
eNursing LLC
Eodyne Systems SL
Esco Lifesciences Group
Eyoto Group Ltd
Fairtility
FIGUR8 Inc
FlowView Diagnostics BV
GE Healthcare
General Hospital of the People's Liberation Army
Georgia Institute of Technology
Griffith University
Guerbet SA
H. Lee Moffitt Cancer Center & Research Institute Inc
Healthplus.ai BV
HealthTech Solutions LLC
Hemeo BV
Henry Ford Health System
Hera MI
Hitachi Ltd
Hospital del Mar
iHealthLabs Europe
Ilex Medical Ltd
Imaxdi.
Imperial College London
Increase Co Ltd
Industrial Technology Research Institute
InformAI LLC
Inpro medical LLC
InsightRX Inc
IXICO Plc
Johns Hopkins Kimmel Cancer Center
Jozef Stefan Institute
Koios Medical
Koninklijke Philips NV
LivaNova PLC
Logical Images Inc
Lucence Diagnostics Pte Ltd
Lucile Packard Children's Hospital Stanford
Macuject Pty Ltd
Massachusetts General Hospital
Max Planck Institute for Biological Cybernetics
MaxQ-AI
Mayo Clinic
MedHub-AI
Medial EarlySign Ltd
Medibio Ltd
MediLogos Ltd
Meir Medical Center
Merative LP
Merck & Co Inc
MetaboList Ltd
Minnesota Health Solutions Corporation
MobileODT Ltd
Monash University
MS Technologies Corp
Nadav-Diagnosis and Medical Treatment Ltd
Nalagenetics Pte Ltd
Nano4Imaging GmbH
National Centre of Scientific Research DEMOKRITOS
National Decision Support Co
National Institute for Health Research Maudsley Biomedical Research Centre
Natus Medical Inc
Naval Medical Research Center
Nervio Ltd
Neurocognitive technologies
Neurozen Inc
New York University
NICo-Lab BV
Northeastern Illinois University
Nuvo Group Ltd
Odin Medical Ltd
Ohio State University
Ohio University
Oncoradiomics SA
Onward Health
OpGen Inc
Optimata Ltd
OTU Medical Inc
Oxford Immunotec Ltd
Paige.AI Inc
PD Theranostics Inc
Pennsylvania State University
Penumbra Inc
Perspectum Diagnostics Ltd
PG Medical Systems Ltd
Picofemto LLC
PKS Holdings Ltd
Potrero Medical Inc
Predictive Medical Technologies, Inc.
Presagen Pty Ltd
PreTel Inc
Procagen Inc
Queensland University of Technology
QUIBIM SL
Radboud University Medical Center
Relate XR LLC
Remidio Innovative Solutions Pvt Ltd
Renalytix AI Plc
Retinalyze, LLC
SAS Anapix Medical
SelfBack ApS
Sensyne Health Plc
Shanghai Pulse Medical Technology Inc
Siemens Healthineers AG
SimBioSys Inc
Solvd Health
Sonio SAS
Stanford University School of Medicine
Swinburne University of Technology
SyntheticMR AB
Tactum Ltd
TaiHao Medical Inc
Tailor Bio Ltd
Taliaz Health Ltd
Telstra Health Pty Ltd
Tempus Health Inc
Tenac.io Inc
The Feinstein Institute for Medical Research
The George Institute for Global Health
The Hospital for Sick Children
The Sheikh Zayed Institute for Pediatric Surgical Innovation
Therapeutic Monitoring Systems Inc. (TMS)
UMass Chan Medical School
Unanimous AI Inc
University College London
University Hospital of Parma
University of Arkansas
University of California Los Angeles
University of Canterbury
University of Colorado Denver
University of Edinburgh
University of Liverpool
University of Michigan
University of New Mexico
University of North Carolina at Chapel Hill
University of Pittsburgh
University of Sao Paulo
University of South Australia
University of South Florida
University of Utah
University of Utah Health Care
University of Vermont
Verily Life Sciences
Visom Technology Inc
VISOON SAS
Volpara Health Technologies Ltd
Voluntis SA
Voxel Healthcare LLC
VoxNeuro
Vyant Bio Inc
Wake Forest Baptist Medical Center
Washington University in St Louis
WISER Systems Inc
x-cardiac GmbH
xCures Inc
Ziliomics Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 13

|1.2 List of Figures 31

2 Introduction 32

2.1 Clinical Decision Support Systems Overview 32

3 Products under Development 33

3.1 Clinical Decision Support Systems – Pipeline Products by Stage of Development 33

3.2 Clinical Decision Support Systems – Pipeline Products by Territory 34

3.3 Clinical Decision Support Systems – Pipeline Products by Regulatory Path 36

3.4 Clinical Decision Support Systems – Pipeline Products by Estimated Approval Date 37

3.5 Clinical Decision Support Systems – Ongoing Clinical Trials 38

4 Clinical Decision Support Systems – Pipeline Products under Development by Companies 39

4.1 Clinical Decision Support Systems Companies – Pipeline Products by Stage of Development 39

4.2 Clinical Decision Support Systems – Pipeline Products by Stage of Development 48

5 Clinical Decision Support Systems Companies and Product Overview 56

5.1 Aalborg University Company Overview 56

5.1.1 Aalborg University Pipeline Products & Ongoing Clinical Trials Overview 56

5.2 Abiomed Inc Company Overview 59

5.2.1 Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.3 Aclarion Inc Company Overview 60

5.3.1 Aclarion Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.4 Adaptive Technology Consulting LLC Company Overview 63

5.4.1 Adaptive Technology Consulting LLC Pipeline Products & Ongoing Clinical Trials Overview 63

5.5 Admera Health LLC Company Overview 64

5.5.1 Admera Health LLC Pipeline Products & Ongoing Clinical Trials Overview 64

5.6 Advinow Inc Company Overview 65

5.6.1 Advinow Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.7 AHEPA University Hospital Company Overview 66

5.7.1 AHEPA University Hospital Pipeline Products & Ongoing Clinical Trials Overview 66

5.8 AI Medical Technology AB Company Overview 67

5.8.1 AI Medical Technology AB Pipeline Products & Ongoing Clinical Trials Overview 67

5.9 ai4gi Solutions Inc Company Overview 70

5.9.1 ai4gi Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.10 AI4medicine Company Overview 71

5.10.1 AI4medicine Pipeline Products & Ongoing Clinical Trials Overview 71

5.11 Ai-Assisted Hematologic Analytic and Decision Support Company Overview 72

5.11.1 Ai-Assisted Hematologic Analytic and Decision Support Pipeline Products & Ongoing Clinical Trials Overview 72

5.12 Aidoc Ltd Company Overview 73

5.12.1 Aidoc Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

5.13 Aifred Health Inc Company Overview 75

5.13.1 Aifred Health Inc Pipeline Products & Ongoing Clinical Trials Overview 75

5.14 Aignostics GmbH Company Overview 78

5.14.1 Aignostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 78

5.15 AirStrip Technologies Inc Company Overview 79

5.15.1 AirStrip Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.16 Alan Turing Institute Almere Company Overview 82

5.16.1 Alan Turing Institute Almere Pipeline Products & Ongoing Clinical Trials Overview 82

5.17 AlertWatch Inc Company Overview 83

5.17.1 AlertWatch Inc Pipeline Products & Ongoing Clinical Trials Overview 83

5.18 AlgorithmRx, LLC Company Overview 87

5.18.1 AlgorithmRx, LLC Pipeline Products & Ongoing Clinical Trials Overview 87

5.19 All India Institute of Medical Sciences Company Overview 88

5.19.1 All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 88

5.20 Allegheny-Singer Research Institute Company Overview 89

5.20.1 Allegheny-Singer Research Institute Pipeline Products & Ongoing Clinical Trials Overview 89

5.21 American College of Rheumatology Company Overview 90

5.21.1 American College of Rheumatology Pipeline Products & Ongoing Clinical Trials Overview 90

5.22 Ampel BioSolutions LLC Company Overview 91

5.22.1 Ampel BioSolutions LLC Pipeline Products & Ongoing Clinical Trials Overview 91

5.23 Analytic Diabetic Systems, LLC Company Overview 93

5.23.1 Analytic Diabetic Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 93

5.24 Anumana Inc Company Overview 94

5.24.1 Anumana Inc Pipeline Products & Ongoing Clinical Trials Overview 94

5.25 Apollo Medical Imaging Technology Pty Ltd Company Overview 100

5.25.1 Apollo Medical Imaging Technology Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 100

5.26 Arne BV Company Overview 101

5.26.1 Arne BV Pipeline Products & Ongoing Clinical Trials Overview 101

5.27 Atomo Inc Company Overview 102

5.27.1 Atomo Inc Pipeline Products & Ongoing Clinical Trials Overview 102

5.28 Auckland University of Technology Company Overview 103

5.28.1 Auckland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 103

5.29 Automated Reliable Tissue Diagnostics AG Company Overview 104

5.29.1 Automated Reliable Tissue Diagnostics AG Pipeline Products & Ongoing Clinical Trials Overview 104

5.30 Automedics Medical Systems Inc (Inactive) Company Overview 105

5.30.1 Automedics Medical Systems Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 105

5.31 Autonomous Healthcare Inc Company Overview 107

5.31.1 Autonomous Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.32 Bausch & Lomb Inc Company Overview 108

5.32.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 108

5.33 Bayer AG Company Overview 109

5.33.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 109

5.34 Beijing Infervision Technology Co Ltd Company Overview 110

5.34.1 Beijing Infervision Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

5.35 Ben-Gurion University of the Negev Company Overview 114

5.35.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 114

5.36 Berg LLC Company Overview 115

5.36.1 Berg LLC Pipeline Products & Ongoing Clinical Trials Overview 115

5.37 bioMerieux Inc Company Overview 116

5.37.1 bioMerieux Inc Pipeline Products & Ongoing Clinical Trials Overview 116

5.38 BioSensics LLC Company Overview 117

5.38.1 BioSensics LLC Pipeline Products & Ongoing Clinical Trials Overview 117

5.39 Blenderhouse Company Overview 118

5.39.1 Blenderhouse Pipeline Products & Ongoing Clinical Trials Overview 118

5.40 Blue Eye Soft Corp Company Overview 119

5.40.1 Blue Eye Soft Corp Pipeline Products & Ongoing Clinical Trials Overview 119

5.41 Brain Electrophysiology Laboratory LLC Company Overview 120

5.41.1 Brain Electrophysiology Laboratory LLC Pipeline Products & Ongoing Clinical Trials Overview 120

5.42 Brainomix Ltd Company Overview 121

5.42.1 Brainomix Ltd Pipeline Products & Ongoing Clinical Trials Overview 121

5.43 BrightOutcome Inc. Company Overview 122

5.43.1 BrightOutcome Inc. Pipeline Products & Ongoing Clinical Trials Overview 122

5.44 Cardiogram Inc Company Overview 125

5.44.1 Cardiogram Inc Pipeline Products & Ongoing Clinical Trials Overview 125

5.45 CareDx Inc Company Overview 126

5.45.1 CareDx Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.46 Carevive Systems Inc Company Overview 128

5.46.1 Carevive Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 128

5.47 Carnegie Mellon University Company Overview 129

5.47.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 129

5.48 Case Western Reserve University Company Overview 130

5.48.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 130

5.49 Cellnovo Ltd (Inactive) Company Overview 131

5.49.1 Cellnovo Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 131

5.50 Children’s Hospital of Philadelphia Company Overview 132

5.50.1 Children’s Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview 132

5.51 Children’s Research Institute Company Overview 133

5.51.1 Children’s Research Institute Pipeline Products & Ongoing Clinical Trials Overview 133

5.52 Cohere Health Technologies LLC Company Overview 134

5.52.1 Cohere Health Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 134

5.53 Columbia University Company Overview 135

5.53.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 135

5.54 Combinostics Oy Company Overview 136

5.54.1 Combinostics Oy Pipeline Products & Ongoing Clinical Trials Overview 136

5.55 Computer Technology Associates Inc Company Overview 138

5.55.1 Computer Technology Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 138

5.56 ContextVision AB Company Overview 141

5.56.1 ContextVision AB Pipeline Products & Ongoing Clinical Trials Overview 141

5.57 Corin Group Ltd Company Overview 143

5.57.1 Corin Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 143

5.58 CorticoMetrics LLC Company Overview 144

5.58.1 CorticoMetrics LLC Pipeline Products & Ongoing Clinical Trials Overview 144

5.59 Crosscope Inc Company Overview 145

5.59.1 Crosscope Inc Pipeline Products & Ongoing Clinical Trials Overview 145

5.60 Cumulus Neuroscience Ltd Company Overview 146

5.60.1 Cumulus Neuroscience Ltd Pipeline Products & Ongoing Clinical Trials Overview 146

5.61 Curemetrix Inc Company Overview 147

5.61.1 Curemetrix Inc Pipeline Products & Ongoing Clinical Trials Overview 147

5.62 Dascena Inc Company Overview 152

5.62.1 Dascena Inc Pipeline Products & Ongoing Clinical Trials Overview 152

5.63 Daxor Corp Company Overview 155

5.63.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 155

5.64 Deontics Ltd Company Overview 156

5.64.1 Deontics Ltd Pipeline Products & Ongoing Clinical Trials Overview 156

5.65 Directed Systems Ltd Company Overview 159

5.65.1 Directed Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 159

5.66 Doctrin AB Company Overview 160

5.66.1 Doctrin AB Pipeline Products & Ongoing Clinical Trials Overview 160

5.67 Dokkyo Medical University Company Overview 161

5.67.1 Dokkyo Medical University Pipeline Products & Ongoing Clinical Trials Overview 161

5.68 DSX Therapeutics LLC Company Overview 164

5.68.1 DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 164

5.69 Eko Devices Inc Company Overview 165

5.69.1 Eko Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 165

5.70 Embryonics Ltd Company Overview 167

5.70.1 Embryonics Ltd Pipeline Products & Ongoing Clinical Trials Overview 167

5.71 Encompass Health Corp Company Overview 168

5.71.1 Encompass Health Corp Pipeline Products & Ongoing Clinical Trials Overview 168

5.72 Ensofy Inc Company Overview 169

5.72.1 Ensofy Inc Pipeline Products & Ongoing Clinical Trials Overview 169

5.73 eNursing LLC Company Overview 170

5.73.1 eNursing LLC Pipeline Products & Ongoing Clinical Trials Overview 170

5.74 Eodyne Systems SL Company Overview 171

5.74.1 Eodyne Systems SL Pipeline Products & Ongoing Clinical Trials Overview 171

5.75 Esco Lifesciences Group Company Overview 172

5.75.1 Esco Lifesciences Group Pipeline Products & Ongoing Clinical Trials Overview 172

5.76 Eyoto Group Ltd Company Overview 173

5.76.1 Eyoto Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 173

5.77 Fairtility Company Overview 174

5.77.1 Fairtility Pipeline Products & Ongoing Clinical Trials Overview 174

5.78 FIGUR8 Inc Company Overview 177

5.78.1 FIGUR8 Inc Pipeline Products & Ongoing Clinical Trials Overview 177

5.79 FlowView Diagnostics BV Company Overview 180

5.79.1 FlowView Diagnostics BV Pipeline Products & Ongoing Clinical Trials Overview 180

5.80 GE Healthcare Company Overview 181

5.80.1 GE Healthcare Pipeline Products & Ongoing Clinical Trials Overview 181

5.81 General Hospital of the People’s Liberation Army Company Overview 182

5.81.1 General Hospital of the People’s Liberation Army Pipeline Products & Ongoing Clinical Trials Overview 182

5.82 Georgia Institute of Technology Company Overview 185

5.82.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 185

5.83 Griffith University Company Overview 186

5.83.1 Griffith University Pipeline Products & Ongoing Clinical Trials Overview 186

5.84 Guerbet SA Company Overview 187

5.84.1 Guerbet SA Pipeline Products & Ongoing Clinical Trials Overview 187

5.85 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 188

5.85.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 188

5.86 Healthplus.ai BV Company Overview 190

5.86.1 Healthplus.ai BV Pipeline Products & Ongoing Clinical Trials Overview 190

5.87 HealthTech Solutions LLC Company Overview 191

5.87.1 HealthTech Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview 191

5.88 Hemeo BV Company Overview 192

5.88.1 Hemeo BV Pipeline Products & Ongoing Clinical Trials Overview 192

5.89 Henry Ford Health System Company Overview 193

5.89.1 Henry Ford Health System Pipeline Products & Ongoing Clinical Trials Overview 193

5.90 Hera MI Company Overview 194

5.90.1 Hera MI Pipeline Products & Ongoing Clinical Trials Overview 194

5.91 Hitachi Ltd Company Overview 195

5.91.1 Hitachi Ltd Pipeline Products & Ongoing Clinical Trials Overview 195

5.92 Hospital del Mar Company Overview 196

5.92.1 Hospital del Mar Pipeline Products & Ongoing Clinical Trials Overview 196

5.93 iHealthLabs Europe Company Overview 199

5.93.1 iHealthLabs Europe Pipeline Products & Ongoing Clinical Trials Overview 199

5.94 Ilex Medical Ltd Company Overview 202

5.94.1 Ilex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 202

5.95 Imaxdi. Company Overview 203

5.95.1 Imaxdi. Pipeline Products & Ongoing Clinical Trials Overview 203

5.96 Imperial College London Company Overview 204

5.96.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 204

5.97 Increase Co Ltd Company Overview 205

5.97.1 Increase Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 205

5.98 Industrial Technology Research Institute Company Overview 208

5.98.1 Industrial Technology Research Institute Pipeline Products & Ongoing Clinical Trials Overview 208

5.99 InformAI LLC Company Overview 209

5.99.1 InformAI LLC Pipeline Products & Ongoing Clinical Trials Overview 209

5.100 Inpro medical LLC Company Overview 212

5.100.1 Inpro medical LLC Pipeline Products & Ongoing Clinical Trials Overview 212

5.101 InsightRX Inc Company Overview 213

5.101.1 InsightRX Inc Pipeline Products & Ongoing Clinical Trials Overview 213

5.102 IXICO Plc Company Overview 216

5.102.1 IXICO Plc Pipeline Products & Ongoing Clinical Trials Overview 216

5.103 Johns Hopkins Kimmel Cancer Center Company Overview 219

5.103.1 Johns Hopkins Kimmel Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 219

5.104 Jozef Stefan Institute Company Overview 220

5.104.1 Jozef Stefan Institute Pipeline Products & Ongoing Clinical Trials Overview 220

5.105 Koios Medical Company Overview 221

5.105.1 Koios Medical Pipeline Products & Ongoing Clinical Trials Overview 221

5.106 Koninklijke Philips NV Company Overview 223

5.106.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 223

5.107 LivaNova PLC Company Overview 225

5.107.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 225

5.108 Logical Images Inc Company Overview 226

5.108.1 Logical Images Inc Pipeline Products & Ongoing Clinical Trials Overview 226

5.109 Lucence Diagnostics Pte Ltd Company Overview 227

5.109.1 Lucence Diagnostics Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 227

5.110 Lucile Packard Children’s Hospital Stanford Company Overview 228

5.110.1 Lucile Packard Children’s Hospital Stanford Pipeline Products & Ongoing Clinical Trials Overview 228

5.111 Macuject Pty Ltd Company Overview 229

5.111.1 Macuject Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 229

5.112 Massachusetts General Hospital Company Overview 230

5.112.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 230

5.113 Max Planck Institute for Biological Cybernetics Company Overview 233

5.113.1 Max Planck Institute for Biological Cybernetics Pipeline Products & Ongoing Clinical Trials Overview 233

5.114 MaxQ-AI Company Overview 234

5.114.1 MaxQ-AI Pipeline Products & Ongoing Clinical Trials Overview 234

5.115 Mayo Clinic Company Overview 235

5.115.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 235

5.116 MedHub-AI Company Overview 236

5.116.1 MedHub-AI Pipeline Products & Ongoing Clinical Trials Overview 236

5.117 Medial EarlySign Ltd Company Overview 241

5.117.1 Medial EarlySign Ltd Pipeline Products & Ongoing Clinical Trials Overview 241

5.118 Medibio Ltd Company Overview 243

5.118.1 Medibio Ltd Pipeline Products & Ongoing Clinical Trials Overview 243

5.119 MediLogos Ltd Company Overview 245

5.119.1 MediLogos Ltd Pipeline Products & Ongoing Clinical Trials Overview 245

5.120 Meir Medical Center Company Overview 247

5.120.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 247

5.121 Merative LP Company Overview 248

5.121.1 Merative LP Pipeline Products & Ongoing Clinical Trials Overview 248

5.122 Merck & Co Inc Company Overview 250

5.122.1 Merck & Co Inc Pipeline Products & Ongoing Clinical Trials Overview 250

5.123 MetaboList Ltd Company Overview 251

5.123.1 MetaboList Ltd Pipeline Products & Ongoing Clinical Trials Overview 251

5.124 Minnesota Health Solutions Corporation Company Overview 252

5.124.1 Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview 252

5.125 MobileODT Ltd Company Overview 253

5.125.1 MobileODT Ltd Pipeline Products & Ongoing Clinical Trials Overview 253

5.126 Monash University Company Overview 254

5.126.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 254

5.127 MS Technologies Corp Company Overview 255

5.127.1 MS Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview 255

5.128 Nadav-Diagnosis and Medical Treatment Ltd Company Overview 256

5.128.1 Nadav-Diagnosis and Medical Treatment Ltd Pipeline Products & Ongoing Clinical Trials Overview 256

5.129 Nalagenetics Pte Ltd Company Overview 257

5.129.1 Nalagenetics Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 257

5.130 Nano4Imaging GmbH Company Overview 260

5.130.1 Nano4Imaging GmbH Pipeline Products & Ongoing Clinical Trials Overview 260

5.131 National Centre of Scientific Research DEMOKRITOS Company Overview 261

5.131.1 National Centre of Scientific Research DEMOKRITOS Pipeline Products & Ongoing Clinical Trials Overview 261

5.132 National Decision Support Co Company Overview 262

5.132.1 National Decision Support Co Pipeline Products & Ongoing Clinical Trials Overview 262

5.133 National Institute for Health Research Maudsley Biomedical Research Centre Company Overview 264

5.133.1 National Institute for Health Research Maudsley Biomedical Research Centre Pipeline Products & Ongoing Clinical Trials Overview 264

5.134 Natus Medical Inc Company Overview 267

5.134.1 Natus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 267

5.135 Naval Medical Research Center Company Overview 268

5.135.1 Naval Medical Research Center Pipeline Products & Ongoing Clinical Trials Overview 268

5.136 Nervio Ltd Company Overview 269

5.136.1 Nervio Ltd Pipeline Products & Ongoing Clinical Trials Overview 269

5.137 Neurocognitive technologies Company Overview 270

5.137.1 Neurocognitive technologies Pipeline Products & Ongoing Clinical Trials Overview 270

5.138 Neurozen Inc Company Overview 271

5.138.1 Neurozen Inc Pipeline Products & Ongoing Clinical Trials Overview 271

5.139 New York University Company Overview 272

5.139.1 New York University Pipeline Products & Ongoing Clinical Trials Overview 272

5.140 NICo-Lab BV Company Overview 273

5.140.1 NICo-Lab BV Pipeline Products & Ongoing Clinical Trials Overview 273

5.141 Northeastern Illinois University Company Overview 274

5.141.1 Northeastern Illinois University Pipeline Products & Ongoing Clinical Trials Overview 274

5.142 Nuvo Group Ltd Company Overview 275

5.142.1 Nuvo Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 275

5.143 Odin Medical Ltd Company Overview 276

5.143.1 Odin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 276

5.144 Ohio State University Company Overview 279

5.144.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 279

5.145 Ohio University Company Overview 280

5.145.1 Ohio University Pipeline Products & Ongoing Clinical Trials Overview 280

5.146 Oncoradiomics SA Company Overview 281

5.146.1 Oncoradiomics SA Pipeline Products & Ongoing Clinical Trials Overview 281

5.147 Onward Health Company Overview 294

5.147.1 Onward Health Pipeline Products & Ongoing Clinical Trials Overview 294

5.148 OpGen Inc Company Overview 295

5.148.1 OpGen Inc Pipeline Products & Ongoing Clinical Trials Overview 295

5.149 Optimata Ltd Company Overview 299

5.149.1 Optimata Ltd Pipeline Products & Ongoing Clinical Trials Overview 299

5.150 OTU Medical Inc Company Overview 300

5.150.1 OTU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 300

5.151 Oxford Immunotec Ltd Company Overview 301

5.151.1 Oxford Immunotec Ltd Pipeline Products & Ongoing Clinical Trials Overview 301

5.152 Paige.AI Inc Company Overview 302

5.152.1 Paige.AI Inc Pipeline Products & Ongoing Clinical Trials Overview 302

5.153 PD Theranostics Inc Company Overview 303

5.153.1 PD Theranostics Inc Pipeline Products & Ongoing Clinical Trials Overview 303

5.154 Pennsylvania State University Company Overview 305

5.154.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 305

5.155 Penumbra Inc Company Overview 308

5.155.1 Penumbra Inc Pipeline Products & Ongoing Clinical Trials Overview 308

5.156 Perspectum Diagnostics Ltd Company Overview 309

5.156.1 Perspectum Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 309

5.157 PG Medical Systems Ltd Company Overview 313

5.157.1 PG Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 313

5.158 Picofemto LLC Company Overview 314

5.158.1 Picofemto LLC Pipeline Products & Ongoing Clinical Trials Overview 314

5.159 PKS Holdings Ltd Company Overview 315

5.159.1 PKS Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 315

5.160 Potrero Medical Inc Company Overview 316

5.160.1 Potrero Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 316

5.161 Predictive Medical Technologies, Inc. Company Overview 317

5.161.1 Predictive Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 317

5.162 Presagen Pty Ltd Company Overview 318

5.162.1 Presagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 318

5.163 PreTel Inc Company Overview 319

5.163.1 PreTel Inc Pipeline Products & Ongoing Clinical Trials Overview 319

5.164 Procagen Inc Company Overview 320

5.164.1 Procagen Inc Pipeline Products & Ongoing Clinical Trials Overview 320

5.165 Queensland University of Technology Company Overview 321

5.165.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 321

5.166 QUIBIM SL Company Overview 322

5.166.1 QUIBIM SL Pipeline Products & Ongoing Clinical Trials Overview 322

5.167 Radboud University Medical Center Company Overview 323

5.167.1 Radboud University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 323

5.168 Relate XR LLC Company Overview 324

5.168.1 Relate XR LLC Pipeline Products & Ongoing Clinical Trials Overview 324

5.169 Remidio Innovative Solutions Pvt Ltd Company Overview 325

5.169.1 Remidio Innovative Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 325

5.170 Renalytix AI Plc Company Overview 326

5.170.1 Renalytix AI Plc Pipeline Products & Ongoing Clinical Trials Overview 326

5.171 Retinalyze, LLC Company Overview 331

5.171.1 Retinalyze, LLC Pipeline Products & Ongoing Clinical Trials Overview 331

5.172 SAS Anapix Medical Company Overview 332

5.172.1 SAS Anapix Medical Pipeline Products & Ongoing Clinical Trials Overview 332

5.173 SelfBack ApS Company Overview 333

5.173.1 SelfBack ApS Pipeline Products & Ongoing Clinical Trials Overview 333

5.174 Sensyne Health Plc Company Overview 334

5.174.1 Sensyne Health Plc Pipeline Products & Ongoing Clinical Trials Overview 334

5.175 Shanghai Pulse Medical Technology Inc Company Overview 336

5.175.1 Shanghai Pulse Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 336

5.176 Siemens Healthineers AG Company Overview 344

5.176.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 344

5.177 SimBioSys Inc Company Overview 346

5.177.1 SimBioSys Inc Pipeline Products & Ongoing Clinical Trials Overview 346

5.178 Solvd Health Company Overview 348

5.178.1 Solvd Health Pipeline Products & Ongoing Clinical Trials Overview 348

5.179 Sonio SAS Company Overview 350

5.179.1 Sonio SAS Pipeline Products & Ongoing Clinical Trials Overview 350

5.180 Stanford University School of Medicine Company Overview 352

5.180.1 Stanford University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 352

5.181 Swinburne University of Technology Company Overview 353

5.181.1 Swinburne University of Technology Pipeline Products & Ongoing Clinical Trials Overview 353

5.182 SyntheticMR AB Company Overview 354

5.182.1 SyntheticMR AB Pipeline Products & Ongoing Clinical Trials Overview 354

5.183 Tactum Ltd Company Overview 355

5.183.1 Tactum Ltd Pipeline Products & Ongoing Clinical Trials Overview 355

5.184 TaiHao Medical Inc Company Overview 356

5.184.1 TaiHao Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 356

5.185 Tailor Bio Ltd Company Overview 359

5.185.1 Tailor Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 359

5.186 Taliaz Health Ltd Company Overview 360

5.186.1 Taliaz Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 360

5.187 Telstra Health Pty Ltd Company Overview 364

5.187.1 Telstra Health Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 364

5.188 Tempus Health Inc Company Overview 365

5.188.1 Tempus Health Inc Pipeline Products & Ongoing Clinical Trials Overview 365

5.189 Tenac.io Inc Company Overview 366

5.189.1 Tenac.io Inc Pipeline Products & Ongoing Clinical Trials Overview 366

5.190 The Feinstein Institute for Medical Research Company Overview 367

5.190.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 367

5.191 The George Institute for Global Health Company Overview 368

5.191.1 The George Institute for Global Health Pipeline Products & Ongoing Clinical Trials Overview 368

5.192 The Hospital for Sick Children Company Overview 369

5.192.1 The Hospital for Sick Children Pipeline Products & Ongoing Clinical Trials Overview 369

5.193 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview 372

5.193.1 The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview 372

5.194 Therapeutic Monitoring Systems Inc. (TMS) Company Overview 373

5.194.1 Therapeutic Monitoring Systems Inc. (TMS) Pipeline Products & Ongoing Clinical Trials Overview 373

5.195 UMass Chan Medical School Company Overview 378

5.195.1 UMass Chan Medical School Pipeline Products & Ongoing Clinical Trials Overview 378

5.196 Unanimous AI Inc Company Overview 379

5.196.1 Unanimous AI Inc Pipeline Products & Ongoing Clinical Trials Overview 379

5.197 University College London Company Overview 380

5.197.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 380

5.198 University Hospital of Parma Company Overview 381

5.198.1 University Hospital of Parma Pipeline Products & Ongoing Clinical Trials Overview 381

5.199 University of Arkansas Company Overview 382

5.199.1 University of Arkansas Pipeline Products & Ongoing Clinical Trials Overview 382

5.200 University of California Los Angeles Company Overview 383

5.200.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 383

5.201 University of Canterbury Company Overview 384

5.201.1 University of Canterbury Pipeline Products & Ongoing Clinical Trials Overview 384

5.202 University of Colorado Denver Company Overview 385

5.202.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 385

5.203 University of Edinburgh Company Overview 386

5.203.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 386

5.204 University of Liverpool Company Overview 391

5.204.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 391

5.205 University of Michigan Company Overview 392

5.205.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 392

5.206 University of New Mexico Company Overview 393

5.206.1 University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 393

5.207 University of North Carolina at Chapel Hill Company Overview 394

5.207.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 394

5.208 University of Pittsburgh Company Overview 396

5.208.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 396

5.209 University of Sao Paulo Company Overview 397

5.209.1 University of Sao Paulo Pipeline Products & Ongoing Clinical Trials Overview 397

5.210 University of South Australia Company Overview 400

5.210.1 University of South Australia Pipeline Products & Ongoing Clinical Trials Overview 400

5.211 University of South Florida Company Overview 401

5.211.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 401

5.212 University of Utah Company Overview 403

5.212.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 403

5.213 University of Utah Health Care Company Overview 404

5.213.1 University of Utah Health Care Pipeline Products & Ongoing Clinical Trials Overview 404

5.214 University of Vermont Company Overview 405

5.214.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview 405

5.215 Verily Life Sciences Company Overview 406

5.215.1 Verily Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 406

5.216 Visom Technology Inc Company Overview 407

5.216.1 Visom Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 407

5.217 VISOON SAS Company Overview 408

5.217.1 VISOON SAS Pipeline Products & Ongoing Clinical Trials Overview 408

5.218 Volpara Health Technologies Ltd Company Overview 409

5.218.1 Volpara Health Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 409

5.219 Voluntis SA Company Overview 410

5.219.1 Voluntis SA Pipeline Products & Ongoing Clinical Trials Overview 410

5.220 Voxel Healthcare LLC Company Overview 415

5.220.1 Voxel Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 415

5.221 VoxNeuro Company Overview 417

5.221.1 VoxNeuro Pipeline Products & Ongoing Clinical Trials Overview 417

5.222 Vyant Bio Inc Company Overview 421

5.222.1 Vyant Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 421

5.223 Wake Forest Baptist Medical Center Company Overview 422

5.223.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 422

5.224 Washington University in St Louis Company Overview 425

5.224.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 425

5.225 WISER Systems Inc Company Overview 426

5.225.1 WISER Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 426

5.226 x-cardiac GmbH Company Overview 427

5.226.1 x-cardiac GmbH Pipeline Products & Ongoing Clinical Trials Overview 427

5.227 xCures Inc Company Overview 428

5.227.1 xCures Inc Pipeline Products & Ongoing Clinical Trials Overview 428

5.228 Ziliomics Inc Company Overview 429

5.228.1 Ziliomics Inc Pipeline Products & Ongoing Clinical Trials Overview 429

6 Clinical Decision Support Systems- Recent Developments 430

6.1 Oct 11, 2022: Flatiron Health Expands Leadership Team with Two New Executive Hires 430

6.2 Sep 07, 2022: epocrates Launches Bugs + Drugs Tool to Promote Optimal Antibiotic Prescribing Amid Healthcare’s Growing Antimicrobial Resistance Crisis 430

6.3 Aug 30, 2022: AirStrip Appoints Eric Brill as Sr. Vice President of Clinical Alarm Communications and Care Coordination 431

6.4 Jul 22, 2022: Roper Technologies Announces Second Quarter Financial Results 431

6.5 Jul 20, 2022: WSO2 appoints Moses Mathuram as vice president of GSI alliances and strategic partnerships 433

6.6 Jul 12, 2022: Etiometry expands AI software platform portfolio with 2 new FDA-cleared algorithms for managing critical care patients 434

6.7 Jun 22, 2022: Arrive Health launches to focus on accessible and affordable healthcare 434

6.8 Jun 01, 2022: Flatiron Health Welcomes Javier Jimenez as Chief Medical Officer 435

6.9 May 27, 2022: Syapse unveils two new studies on use of machine learning on real-world data to identify and treat cancer with precision at ASCO 2022 436

6.10 May 26, 2022: Flatiron Health announces research to be presented at American Society of Clinical Oncology 2022 Annual Meeting 436

6.11 Apr 26, 2022: RxRevu significantly expands health system network to meet patient affordability demands 437

6.12 Apr 21, 2022: CareCloud to Attend Becker’s 12th Annual Meeting 438

6.13 Apr 06, 2022: East Lancashire Hospitals NHS Trust signs 5 year Miya Flow contract 438

6.14 Mar 16, 2022: RxRevu’s rapid growth enables patient affordability and access to care 439

6.15 Mar 07, 2022: Clinical decision support system reduces cardiovascular risk in patients with serious mental illness 440

6.16 Jan 20, 2022: Etiometry surpasses 100 contracted units in year of record growth 441

6.17 Dec 16, 2021: Protocol first joins flatiron health 442

6.18 Dec 06, 2021: Syapse announces new studies published at Virtual ISPOR Europe 2021 442

6.19 Nov 03, 2021: Change Healthcare Reports Second Quarter Fiscal 2022 Financial Results 443

7 Appendix 446

7.1 Methodology 446

7.2 About GlobalData 449

7.3 Contact Us 449

7.4 Disclaimer 449

 

Frequently asked questions

Clinical Decision Support Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Clinical Decision Support Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Healthcare IT reports
Medical Devices
India Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | December 2021
Medical Devices
Japan Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | December 2021
Medical Devices
New Zealand Surgical Energy Instruments Market Size (Value, Volume, ASP)…
$500 | December 2021
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Clinical Decision Support Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Clinical Decision Support Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more